Drugs / Cardiopeptidin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06117046 | Feb → Nov 2023 | — | Nanfang Hospital, Southern Medical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cardiopeptidin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06117046 ↗ |
| Route | Intravenous | “Cardiopeptidin was administered intravenously” NCT06117046 ↗ |